<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01271647</url>
  </required_header>
  <id_info>
    <org_study_id>LHCTOP2011</org_study_id>
    <nct_id>NCT01271647</nct_id>
  </id_info>
  <brief_title>Classic Yin and Yang Tonic Formula for Osteopenia</brief_title>
  <acronym>CYYTO</acronym>
  <official_title>Randomized Controlled Trial of Classic Yin and Yang Tonic Formula in Osteopenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Science and Technology of the PeopleÂ´s Republic of China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai University of Traditional Chinese Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of the classic yin and yang
      tonic formula for osteopenia and to research the mechanism of efficacy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Osteoporosis is a growing problem worldwide, with the greatest burden resulting from
      fractures. Nevertheless, the majority of fractures in adults occur in those with &quot;osteopenia&quot;
      (bone mineral density (BMD) only moderately lower than young normal individuals) Since life
      long drug therapy is an expensive option with uncertain consequences and side effect, natural
      herbal therapy offers an attractive alternative. The classic Yin and Yang Tonic Formula
      (eg.Zuogui Pill, Yougui Pill) have been used for osteoporosis or osteopenia in traditional
      Chinese medicine(TCM) for a long time. For this reason, Chinese guidelines for the treatment
      of osteopenia include natural herbal therapy, however, there is currently no randomize
      placebo controlled trial to verify the efficacy for treating low BMD. This trial is
      randomized, double blind, placebo controlled design. Results of this study will provide
      evidence regarding the value of the classic Yin and Yang tonic formula as an intervention for
      increase BMD and decreasing fracture risk in osteopenia. Furthermore, the mechanisms of
      action can be identified by this study.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">July 2012</completion_date>
  <primary_completion_date type="Anticipated">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>bone mineral density</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain visual analogue scales,ECOS-16 questionnaire,bone metabolism,NEI.</measure>
    <time_frame>6 months</time_frame>
    <description>pain visual analogue scales:6month ECOS-16 questionnaire:6month bone metabolism,NEI:6month</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Osteopenia</condition>
  <arm_group>
    <arm_group_label>chinese herb</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Yin and Yang tonic granules</intervention_name>
    <description>Yin and Yang tonic granules,18g per time,two times per day,six months</description>
    <arm_group_label>chinese herb</arm_group_label>
    <other_name>Zuo and You gui Granules</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>granules,18g per time,two times per day,six months</description>
    <arm_group_label>placebo</arm_group_label>
    <other_name>Zuo and You gui Granules</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMD T-scores of the hip (femoral neck or trochanter)and/or spine between -1.0 and
             -2.5;

          -  pattern differentiation is kidney deficiency in TCM.

          -  informed consent.

        Exclusion Criteria:

          -  Osteoporotic (T-score&lt; -2.5) at any site or a fracture in the past 2 years not caused
             by motor vehicle accident;

          -  prior or current use of medication that increase risks of fracture (e.g. steroids,
             anti-convulsants, anticoagulants,lithium);

          -  prior or current use of medications that modify bone metabolism (e.g. bisphosphonates,
             selective estrogen receptor modulators such as Raloxifene);

          -  use of calcium supplements above levels suggested within the recommendations of
             standard care (i.e., above 1200-1500 mg);

          -  current or prior year use of estrogen or calcitonin;

          -  Malignancies other than skin cancer;

          -  conditions that cause secondary osteoporosis (e.g. Cushing's syndrome, Marfan's
             syndrome);

          -  lactation and gestational period;

          -  physical or mental disabilities that will preclude informed consent or active study
             participation;

          -  supersensitivity body constitution.

          -  osteoporotic fracture of having operating indication.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>feng yang, doctor</last_name>
    <role>Study Director</role>
    <affiliation>Shanghai UTCM</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>yongjun wang, doctor</last_name>
    <phone>0086-21-64385700-6403</phone>
    <email>yjwang88@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>feng yang, doctor</last_name>
    <phone>008615001721036</phone>
    <email>yangfengdudu@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Longhua Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>xuejun cui, Dr.</last_name>
      <phone>0086-18917763017</phone>
      <email>diyicuixj@163.com</email>
    </contact>
    <contact_backup>
      <last_name>feng yang, Dr.</last_name>
      <phone>0086-15001721036</phone>
      <email>yangfengdudu@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2011</study_first_submitted>
  <study_first_submitted_qc>January 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2011</study_first_posted>
  <last_update_submitted>July 26, 2011</last_update_submitted>
  <last_update_submitted_qc>July 26, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2011</last_update_posted>
  <responsible_party>
    <name_title>yongjun wang</name_title>
    <organization>Shanghai UTCM</organization>
  </responsible_party>
  <keyword>osteopenia,chinese herb</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

